South Dakota Investment Council - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
South Dakota Investment Council ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$10,716,000
+53.2%
1,777,037
-8.5%
0.22%
+63.5%
Q3 2019$6,995,000
+47.0%
1,943,097
+9.5%
0.14%
+38.4%
Q2 2019$4,757,000
-13.1%
1,775,127
-4.0%
0.10%
-14.7%
Q1 2019$5,476,000
-25.1%
1,850,002
-39.1%
0.12%
+36.5%
Q4 2018$7,310,000
+67.4%
3,037,004
+155.9%
0.08%
-10.5%
Q3 2018$4,368,000
+106.4%
1,187,002
+58.8%
0.10%
+106.5%
Q2 2018$2,116,000
-31.5%
747,600
-10.1%
0.05%
-35.2%
Q1 2018$3,087,000
+28.8%
832,0000.0%0.07%
+34.0%
Q4 2017$2,396,000
-36.7%
832,000
-1.4%
0.05%
-31.2%
Q3 2017$3,787,000
-2.2%
843,5000.0%0.08%
-6.1%
Q2 2017$3,872,000
+9.0%
843,5000.0%0.08%
+13.9%
Q1 2017$3,551,000
+1.9%
843,5000.0%0.07%
-2.7%
Q4 2016$3,484,000
-35.9%
843,500
+25.8%
0.07%
-33.9%
Q3 2016$5,432,000
+3.8%
670,6000.0%0.11%
-2.6%
Q2 2016$5,231,000
-4.8%
670,600
-5.7%
0.12%
-4.2%
Q1 2016$5,493,000
-23.7%
711,500
+6.6%
0.12%
-24.1%
Q4 2015$7,201,000
+51.0%
667,400
-3.3%
0.16%
+43.6%
Q3 2015$4,770,000
-22.0%
690,3000.0%0.11%
-10.6%
Q2 2015$6,116,000
-15.1%
690,300
-5.6%
0.12%
-10.9%
Q1 2015$7,208,000
-22.8%
731,000
-4.1%
0.14%
-24.6%
Q4 2014$9,339,000
+65.6%
762,400
+35.0%
0.18%
+60.5%
Q3 2014$5,638,000564,9000.11%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
RA Capital Management 12,033,220$92,896,00011.87%
RTW INVESTMENTS, LP 2,558,859$19,754,0007.17%
TURNER INVESTMENTS LLC 859,560$6,636,0001.80%
DAFNA Capital Management LLC 236,500$1,826,0001.58%
Ghost Tree Capital, LLC 250,000$1,930,0001.09%
Orbimed Advisors 11,519,700$88,932,0000.94%
Rock Springs Capital Management LP 1,220,000$9,418,0000.79%
Opus Point Partners Management, LLC 99,000$764,0000.59%
Bellevue Group AG 420,000$3,242,0000.59%
Cormorant Asset Management, LP 500,000$3,860,0000.58%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders